Gene find could lead to treatment for memory loss

Image
ANI Washington D.C. [USA]
Last Updated : Jun 01 2017 | 9:48 AM IST

More than 100 genes linked to memory have been identified, paving the way for treatments for conditions like epilepsy and Alzheimer's disease.

A study at the Peter O'Donnell Jr. Brain Institute includes the results of a new strategy to identify genes that underlie specific brain processes. This strategy may eventually help scientists develop treatments for patients with memory impairments.

"Our results have provided a lot of new entry points into understanding human memory," said researcher Genevieve Konopka. "Many of these genes were not previously linked to memory, but now any number of labs could study them and understand their basic function in the brain. Are they important for brain development; are they more important for aspects of behaviour in adults?"

The study stems from previous research by Konopka that linked specific genes to resting-state brain behaviour. She wanted to use that same assessment to evaluate brain activity during active information processing.

To do so, she collaborated with Bradley Lega, a neurosurgeon with the O'Donnell Brain Institute conducting memory research on epilepsy patients while helping to locate the source of their seizures. Lega maps the brain waves of these patients to understand what patterns are critical for successful memory formation.

Combining their techniques, the doctors found that a different group of genes is used in memory processing than the genes involved when the brain is in a resting state. A number of them had not previously been linked to any brain process, Konopka said.

Lega is hopeful the findings can help scientists better understand and treat a range of conditions involving memory impairment, from epilepsy to Alzheimer's disease.

He also hopes the study's success in combining genetics and cognitive neuroscience will encourage more scientists to reach beyond their areas of expertise to elevate their research.

The study is published in Cerebral Cortex.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 01 2017 | 9:30 AM IST

Next Story